Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-24 @ 7:36 PM
NCT ID:
NCT00096603
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent
* Previous participation in Study ACD2600g
* For women of childbearing potential, continued use of an acceptable method of contraception for the duration of the study
Exclusion Criteria:
* Any medical condition that, in the judgment of the investigator, would jeopardize the subject's safety following exposure to Efalizumab
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00096603
Study Brief:
Protocol Section:
NCT00096603